L. Milas

3.8k total citations
78 papers, 3.2k citations indexed

About

L. Milas is a scholar working on Oncology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, L. Milas has authored 78 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Oncology, 20 papers in Molecular Biology and 18 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in L. Milas's work include Cancer Cells and Metastasis (13 papers), Effects of Radiation Exposure (13 papers) and Cancer Research and Treatments (8 papers). L. Milas is often cited by papers focused on Cancer Cells and Metastasis (13 papers), Effects of Radiation Exposure (13 papers) and Cancer Research and Treatments (8 papers). L. Milas collaborates with scholars based in United States, Croatia and Belgium. L. Milas's co-authors include Nancy Hunter, K.A. Mason, Kathryn A. Mason, L. Clifton Stephens, R.E. Meyn, H. Rodney Withers, L.J. Peters, K.K. Ang, L. J. Peters and Helen B. Stone and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Journal of Controlled Release.

In The Last Decade

L. Milas

77 papers receiving 3.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L. Milas United States 29 1.4k 983 801 655 595 78 3.2k
Gordon W. Philpott United States 29 998 0.7× 528 0.5× 755 0.9× 837 1.3× 1.0k 1.7× 61 3.2k
S. E. Salmon United States 33 1.9k 1.3× 1.7k 1.7× 424 0.5× 365 0.6× 404 0.7× 78 3.9k
Raymond Taetle United States 38 1.2k 0.9× 2.2k 2.2× 267 0.3× 518 0.8× 309 0.5× 129 4.4k
Anne W. Hamburger United States 29 2.2k 1.5× 2.7k 2.8× 555 0.7× 764 1.2× 515 0.9× 110 4.9k
Paul Calabresi United States 31 885 0.6× 1.3k 1.3× 445 0.6× 489 0.7× 221 0.4× 105 3.1k
P R Twentyman United Kingdom 29 1.6k 1.1× 1.5k 1.5× 355 0.4× 532 0.8× 356 0.6× 86 3.1k
Bayard Clarkson United States 22 1.8k 1.2× 1.5k 1.5× 524 0.7× 245 0.4× 252 0.4× 43 4.9k
Shigeki Shimizu Japan 29 1.4k 1.0× 1.0k 1.1× 1.9k 2.4× 481 0.7× 136 0.2× 108 3.5k
Joan M. Carboni United States 34 1.4k 1.0× 2.4k 2.5× 361 0.5× 804 1.2× 111 0.2× 75 4.0k
Jin S. Lee United States 30 1.2k 0.8× 1.3k 1.4× 960 1.2× 466 0.7× 114 0.2× 60 3.4k

Countries citing papers authored by L. Milas

Since Specialization
Citations

This map shows the geographic impact of L. Milas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Milas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Milas more than expected).

Fields of papers citing papers by L. Milas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Milas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Milas. The network helps show where L. Milas may publish in the future.

Co-authorship network of co-authors of L. Milas

This figure shows the co-authorship network connecting the top 25 collaborators of L. Milas. A scholar is included among the top collaborators of L. Milas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Milas. L. Milas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Milas, L., Kathryn A. Mason, & K. Kian Ang. (2003). Epidermal growth factor receptor and its inhibition in radiotherapy:in vivofindings. International Journal of Radiation Biology. 79(7). 539–545. 28 indexed citations
2.
Stockerl‐Goldstein, Keith, L. Milas, Chusilp Charnsangavej, S Wallace, & Chun Li. (2001). Potentiation of radioresponse by polymer–drug conjugates. Journal of Controlled Release. 74(1-3). 237–242. 16 indexed citations
3.
Crane, Christopher H., Nora A. Janjan, Douglas B. Evans, et al.. (2001). Toxicity and Efficacy of Concurrent Gemcitabine and Radiotherapy for Locally Advanced Pancreatic Cancer. International Journal of Gastrointestinal Cancer. 29(1). 9–18. 71 indexed citations
4.
Kishi, Kazushi, Sven Petersen, Cordula Petersen, et al.. (2000). Preferential enhancement of tumor radioresponse by a cyclooxygenase-2 inhibitor.. PubMed. 60(5). 1326–31. 232 indexed citations
5.
Milas, L., Kazushi Kishi, Nancy Hunter, et al.. (1999). Enhancement of Tumor Response to  -Radiation by an Inhibitor of Cyclooxygenase-2 Enzyme. JNCI Journal of the National Cancer Institute. 91(17). 1501–1504. 197 indexed citations
6.
Milross, Christopher, Kathryn A. Mason, Nancy Hunter, et al.. (1997). Enhanced radioresponse of paclitaxel-sensitive and -resistant tumours in vivo. European Journal of Cancer. 33(8). 1299–1308. 45 indexed citations
7.
Bradarić, Nikola, et al.. (1996). Two outbreaks of typhoid fever related to the war in Bosnia and Herzegovina. European Journal of Epidemiology. 12(4). 409–412. 9 indexed citations
8.
Milas, L. & W Hanson. (1995). Eicosanoids and radiation. European Journal of Cancer. 31(10). 1580–1585. 49 indexed citations
9.
Thompson, John R., et al.. (1992). Effects of size and growth time of a murine sarcoma on its metastatic spread. Clinical & Experimental Metastasis. 10(1). 77–86. 1 indexed citations
10.
Milas, L., et al.. (1992). Radiation protection against early and late effects of ionizing irradiation by the prostaglandin inhibitor indomethacin. Advances in Space Research. 12(2-3). 265–271. 18 indexed citations
11.
Milas, L., et al.. (1991). Antitumour Effects of Indomethacin Alone and in Combination with Radiotherapy: Role of Inhibition of Tumour Angiogenesis. International Journal of Radiation Biology. 60(1-2). 65–70. 14 indexed citations
13.
Volpe, John P., et al.. (1990). Metastatic abilities of murine sarcomas and carcinomas. II. Relationship to cell volume and DNA index. Clinical & Experimental Metastasis. 8(2). 193–201. 1 indexed citations
14.
Volpe, John P. & L. Milas. (1990). Influence of tumor transplantation methods on tumor growth rate and metastatic potential of solitary tumors derived from metastases. Clinical & Experimental Metastasis. 8(4). 381–389. 18 indexed citations
15.
Milas, L., et al.. (1989). Tumor bed effect-induced reduction of tumor radiocurability through the increase in hypoxic cell fraction. International Journal of Radiation Oncology*Biology*Physics. 16(1). 139–142. 24 indexed citations
16.
Milas, L., et al.. (1989). Protection of cultured chinese hamster ovary cells by the aminothiol WR-255591 from the lethal and DNA-damaging effects of fast neutrons. International Journal of Radiation Oncology*Biology*Physics. 16(5). 1205–1208. 4 indexed citations
17.
Iwakawa, Mayumi, et al.. (1989). Combination of N-methylformamide with cis-diamminedichloroplatinum (II) in murine mammary carcinoma: importance of timing.. PubMed. 49(7). 1640–3. 12 indexed citations
18.
Milas, L., David Murray, William A. Brock, & R.E. Meyn. (1988). Radioprotectors in tumor radiotherapy: factors and settings determining therapeutic ratio. Pharmacology & Therapeutics. 39(1-3). 179–187. 25 indexed citations
19.
Milas, L., et al.. (1979). Enhancement of artificial lung metastases in mice caused by cyclophosphamide. Cancer Immunology Immunotherapy. 6(3). 17 indexed citations
20.
Milas, L., et al.. (1978). Corynebacterium parvum: Effect on radiocurability of murine tumors. Cancer Immunology Immunotherapy. 5(2). 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026